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Physicians and the general public are increasingly using
web-based tools to ﬁnd answers to medical questions. The
ﬁeld of rare diseases is especially challenging and important
as shown by the long delay and many mistakes associated
with diagnoses. In this paper we review recent initiatives on
the use of web search, social media and data mining in data
repositories for medical diagnosis. We compare the retrieval
accuracy on 56 rare disease cases with known diagnosis for
the web search tools google.com, pubmed.gov, omim.org
and our own search tool ﬁndzebra.com. We give a detailed
description of IBM’s Watson system and make a rough
comparison between ﬁndzebra.com and Watson on subsets
of the Doctor’s dilemma dataset. The recall@10 and recall@20
(fraction of cases where the correct result appears in top 10
and top 20) for the 56 cases are found to be be 29%, 16%,
27% and 59% and 32%, 18%, 34% and 64%, respectively.
Thus, FindZebra has a signiﬁcantly (p < 0.01) higher recall
than the other 3 search engines. When tested under the same
conditions, Watson and FindZebra showed similar recall@10
accuracy. However, the tests were performed on different
subsets of Doctors dilemma questions. Advances in
technology and access to high quality data have opened new
possibilities for aiding the diagnostic process. Specialized
search engines, data mining tools and social media are some
of the areas that hold promise.
Introduction
Many diseases are so rare that a general physician is unlikely to
see a single case in their whole career.1 Furthermore, the symp-
toms of rare diseases are often atypical and can point in many dif-
ferent directions. As a result, the correct diagnosis is often delayed
for several years.1 As a supplement to existing flowcharts for vari-
ous rare diseases, a web tool can suggest possible diagnoses to
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physicians in an easily accessible way, diagnoses which might not
be on the flowcharts since no flow chart is able to cover all the
5000C rare diseases in existence.1 Given a list of possible diagno-
ses, it is easier to request specific biochemical or genetic tests to
confirm or refute the diagnosis than it would be to request the
tests based on atypical symptoms alone. In the latter case, the
requested tests tend to be common laboratory tests which might
not uncover a specific rare disease, thereby contributing to the
delay of the correct diagnosis.
The Cause of Diagnostic Errors
Mark Graber and co-workers have in a series of papers
identified a number of causes for diagnostic errors.2,3,4 They
observed that lack of knowledge is rarely the cause of cogni-
tive errors in medicine but rather involve defective synthesis
of the available information. Graber et al classify the 3 most
common errors as:
 Context errors. The diagnostic possibilities are too restrictive,
for example gastrointestinal causes are not considered for chest
pain symptoms.
 Availability errors. A more likely (common) or a more familiar
diagnosis is preferred.
 Premature closure. Once a plausible diagnosis is identified
alternatives are no longer considered.
Arguably many of these errors occur because the physician has
very limited time to consider each case either alone or with peers
with complementary expertise.5 Web-based tools thus appear as
an obvious candidate to confront these types of errors because
they offer fast access to information and potentially fast communi-
cation with peers. In the remainder of the paper we will describe
recent initiatives within web search, data mining (with special
focus on IBM’s recent Watson system) and social media method-
ology for this. We compare the different tools against each other
on 2 benchmark data sets with paired query (mainly list of symp-
toms) and a known diagnosis. The sections on search and social
media are kept relatively brief because search has been discussed
extensively by us elsewhere6,7 and because the results of social
media initiatives are still hard to quantify. We conclude the paper
with a discussion of how these tools may affect the different types
of errors.
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Web Search for Diagnosis
Physicians use the web as an important resource for medical
information.8,9 Google search and PubMed are arguably the most
popular interfaces to the web for physicians although specialized
resources are also widely used. Google indexes (collects, parses
and stores) more public web data than anyone else and PubMed
hosts the largest database of medical abstracts in the world.
In order to compare these different web search engines, it is
necessary define a suitable performance metric. When a search
engine is used as an aid for compiling a differential diagnosis, we
are not just interested in the most likely disease, but rather in a
list of the most likely diseases. A reasonable performance metric
could therefore be the probability of having the correct diagnosis
in an automatically generated differential diagnosis consisting of
e.g. Ten candidate diseases. This number is called recall@10, and
is how frequent the correct diagnosis appear among the first 10
search results. In this paper we therefore use recall@10 and
recall@20 to compare the performance of the different search
engines, both general purpose (Google search), general medical
literature search (PubMed) and specialized to rare diseases (Find-
Zebra and omim.org).
Performance of Web Search Tools
In our study6 from 2013, we showed that the ranking algo-
rithm used in the search engine has a big influence on the quality
of the results returned. In that study we queried Google, PubMed
and the previous version of FindZebra with lists of symptoms for
a collection of 56 rare disease cases and compared the returned
results with the known diagnosis. In November 2014 we per-
formed the same test again for the current version of PubMed
and FindZebra. Since a majority of the articles indexed by Find-
Zebra are Omim articles, we also performed the test for Omim.
org. Since the publication of our previous study Google has
indexed both the article (containing all question/answer pairs)
and all the case studies used in the test. This means that we would
need a new set of test questions in order to obtain a fair estimate
of the current recall performance of Google. Instead of creating a
new test set we have used the estimated performance for Google
from 2013 as a proxy for the current performance. The results of
the test can be seen in Figure 1. Google, PubMed and Omim
had a success rate of a one-third or less whereas the current ver-
sion of FindZebra was able to retrieve the correct diagnosis
among the top 20 returned results in about 2-third of the 56
cases. One could argue that the superior performance of FindZe-
bra over Google is be due to the fact that Google has to consider
a much larger search space. However, in Google advanced search
(found in the Settings menu in Google Search) it is possible to
specify the web domains used for indexing, and using the same
domains as indexed by FindZebra did not lead to better results
in.6 This has led us to the conclusion that specialized search has a
definite role to play in domains such as rare disease diagnosis.
The 56 questions and the results for each of the search engines
can be found here: http://ec2–54–148–37-23.us-west-2.com-
pute.amazonaws.com:8080/QueriesAndResultsFinalForWeb.xls.
The ranking algorithm used in Google search is highly special-
ized with more than 200 parameters optimized by continuous A/
B-testing on web users. A/B-testing involves dividing a fraction
of the web users into a test group and a control group and then
perform a statistical analysis in order to select the best possible
parameters. This means that Google search will become better
and better on average at answering the queries it receives. But
there is no guarantee that the queries in specialized domains with
little search volume will see an increase in performance. Further-
more, Google has to index huge amounts of data and the results
of a search query must be available within milliseconds. This
huge volume of data puts a computational constraint on the com-
plexity of the ranking algorithm. A specialized search engine, on
the other hand, typically only has to deal with a relatively small
document collection (FindZebra, for example, is based on a doc-
ument collection of only 35.000 documents). Therefore, a spe-
cialized search engine typically has the option of using practically
every tool available within the fields of machine learning and
information retrieval. Until recently, however, the research in
FindZebra has been focused on how to include meta-information
in the articles rather than finding an optimal document model for
ranking. FindZebra currently uses a simple yet highly effective
algorithm that finds and ranks documents by comparing word
counts in the query string to words counts in an expanded docu-
ment corpus. Another advantage that a specialized search engine
typically has compared to a general search engine is that it can
more easily incorporate the use of meta-information. For exam-
ple, Find-Zebra uses information such as symptoms, symptom
equivalence or the fact that 2 articles describe the same disease.
This type of information has the potential to substantially
improve the search results and has already been used with success
in several other search applications. Examples of such applica-
tions are the Phenomizer project for hereditary diseases (comp-
bio.charite.de/phenomizer),10,11,12 SimulConsult (simulconsult.
com), WebMD (symptoms.webmd.com), POSSUM (www.
possum.net.au) and London Medical Databases (www.lmdata-
bases.com/). Phenomizer is a tool that uses the Human Pheno-
type Ontology (HPO) to correlate phenotypic abnormalities
with genetic disorders. WebMD’s symptom checker uses symp-
tom information in order to compile a differential diagnosis.
Figure 1. Performance of different web based search tools on a query
collection consisting of 56 queries from Ref. 6.
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SimulConsult specializes in neurology and genetics, and has a
feature where a medical professional can enter symptoms after
which the system will give a differential diagnosis based on a
probabilistic analysis. London Dysmorphology Database is a
database on rare dysmorphic syndromes that provides informa-
tion on genetic syndromes. It also has a large database of photo-
graphic information, and includes the possibility to register
undiagnosed or unreported cases. POSSUM is a dysmorphology
database that contains textual and photographic information on
more than 3000 malformations, metabolic, teratogenic, chromo-
somal and skeletal syndromes. An overview of these tools are
given in Table 1. In our performance comparison, summarised
in Figure 1, we have limited ourselves to testing the tools that
has a web search interface because this testing requires no addi-
tional medical knowledge and can be performed fast.
That non-Google ranking algorithms do not necessarily work
well is underlined by the poor performance of PubMed. This
probably simply reflects that the search functionality in PubMed
is designed for retrieving information for the more informed case
of knowing for example the author name or keywords. Therefore
it is a poor choice of tool for compiling a differential diagnosis.
The main data source of FindZebra is omim.org (Online Mende-
lian Inheritance in Man). Omim is an online database specializ-
ing in human genes and genetic phenotypes and contains
information on all Mendelian disorders and over 12.000 genes.
22.000 of the the 35.000 documents indexed by FindZebra are
based on articles from OMIM. Omim.org offers a Google like
interface to their articles (i.e. a simple search field) and focuses
exclusively on genetic diseases. Since most rare disease queries are
on genetic diseases, we would expect that the performance of
omim.org is not much worse than FindZebra. Our previous
results, however, show that omim.org has a diffculty ranking the
correct results high. Looking in details (see http://ec2–54–148–
37–23.us-west-2.compute.amazonaws.com:
8080/QueriesAndResultsFinalForWeb.xls), we see that even in
the cases where the FindZebra hit is an OMIM article, the same
article is ranked lower on omim.org. This suggests that there is
potential for optimizing the ranking algorithm in omim.org or
that getting the full potential out of omim.org requires refine-
ments of the search strings.
Non-Professional use of Web Tool for Diagnosis
Physicians are not the only ones using the web for diagnosis. A
recent study13 showed that 35% of all American adults have used
the internet for diagnosis. Of these “online diagnosers,” 46%
went to a physician with their findings and a surprising 41% of
these got a confirmation of their diagnosis. In a previous study it
was shown that the diagnostic success rate for a medical profes-
sional (on a collection of 26 test cases) was approximately 58%
(when using Google as the only tool).9 Although the set-up is
not same in the 2 studies this is indicative that the success rate
might not be that different between professionals and non-pro-
fessionals. It is especially interesting how the web was used for
diagnosis: 77% of the online diagnosers began their exploration
using a search engine such as Google, Bing, or Yahoo. Another
13% began at a website specializing in health information, such
as WebMD and the remaining 10% started the exploration in
other places such as Wikipedia or Facebook. Considering the
Table 1. Overview of the different diagnostic tools mentioned in the article
Use Purpose Web page
FindZebra Free text search with automatic symptom
extraction and inference using Bayesian
networks. Faceted search.
Diagnostic tool for rare diseases (for
professionals)
www.ﬁndzebra.com
London Dysmorphology
Database
Database on rare dysmorphic syndromes Browsable database (for
professionals)
www.lmdatabases.com/
OMIM Free text search Search for articles on ge-Netic
diseases (for professionals)
www.omim.org
Phenomizer Patient features and symptoms are input using a
HPO (Human Phenotype Ontology)
questionnaire. The system uses custom
inference specialized for ontologies
Diagnostic tool for ge-netic diseases
(for professionals)
compbio.charite.de/phenomizer
POSSUM A dysmorphology database of multiple
malformations, metabolic, teratogenic,
chromosomal and skeletal syndromes and their
images
Used for diagnosis and learning (for
professionals)
www.possum.net.au
PubMed Free text search General medical information search
(for professionals)
www.ncbi.nlm.nih.gov/pubmed
SimulConsult Uses Bayesian inference to compile differential
diagnosis
Diagnostic tool specialized for
neurology and genetics (for
professionals)
www.simulconsult.com/
Watson Custom inferential system based on various
statistical methods (see text for details)
General diagnostic tool (for
professionals)
Not publicly accessible
WebMD Search is performed using either free text search or
by using a knowledge based symptom
questionnaire system.
General diagnostic tool (for non-
professionals)
www.webmd.com
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results summarized in Figure 1, the success rate of online diag-
nosers might improve substantially if more specialized tools were
utilized instead of a generalized search engine. It should be noted,
however, that there are mixed opinions14,15,16 whether these tools
in the hands of non-professionals will provide an overall benefit
for diagnosis. One of the major concerns that has been voiced is
that the tools might be used by a non-professional as a diagnostic
procedure where search results are interpreted as diagnostic con-
clusions. This might lead to unnecessary high anxiety levels or
might affect the user’s decision on whether or not to consult a
physician. But like it or not, non-professional “diagnosis” is a
phenomenon that is likely to grow in the years to come.
Data-Mining for Diagnosis
The use of computer systems as an aid in medical diagnosis is
nothing new. The earliest clinical diagnosis decision support sys-
tems (CDDSS) date back to the 1970s. All of these early systems
used knowledge in a structured form (e.g., manually constructed
knowledge bases or relational databases). Two examples of such
early (1970s) systems are the Internist-I system17 and the MYCIN
system.18 The Internist-I system used a database of diseases,
symptoms and sensitivities (the fraction of patients with a disease,
who have the symptom). The MYCIN system was a rule-based
expert system designed to diagnose infectious blood diseases
based on a long series of yes/no or simple textual questions. Dur-
ing the 1990s systems with more sophisticated probabilistic rea-
soning, such as e.g. the Iliad system,19 began to emerge. These
systems were, however, still based on structured knowledge. One
of the major weaknesses of systems relying on structured knowl-
edge alone is that experts are needed in order to update or expand
the knowledge bases. This means that such systems can be diffcult
to keep up to date, especially in a field like medicine, where the
amount of information found in textbooks, case studies, research
articles and so forth doubles approximately every 5 y.20 As a con-
sequence of this exponential increase in information, systems for
medical diagnosis relying on structured information alone are
able to use only an increasingly small fraction of all the available
information. This, of course, does not mean that it is impossible
to construct useful tools using structured information alone.
OMIM, Possum and London Dysmorphology Database are
good examples of very useful tools relying almost purely on struc-
tured information. Even though these tools are kept up to date
within their domain, there is an increasing amount of (unstruc-
tured) information that is not used, and perhaps these tools could
be improved by exploiting this extra information. Our search
engine FindZebra initially started at the other end of the spec-
trum relying purely on unstructured information, but it has since
then evolved to use both structured and unstructured informa-
tion. It is our clear impression that using both types of informa-
tion sources at the same time creates a huge synergetic effect.
Since the late 1990s, several attempts have been made at
building CDDSS systems based at least partly on data mining
instead of handwritten rules.6,21, 22 One of the latest attempts
was based on an open-domain question answering system
called Watson,21 developed by IBM over a 4-year period from
2007 to 2011. The initial purpose of Watson was to see if it
was possible to build a computer system able to compete
against the best human players in the popular game of Jeop-
ardy!. Jeopardy! is a quiz game where 3 contestants compete
against each other at answering a series of questions posed by
a quiz master. The first contestant to hit a buzzer after hearing
a question gets the right to answer that question. Points are
earned by answering correctly and lost by answering incor-
rectly. The winner of the game is the contestant with the most
points at the end. The project became a huge success, and
Watson played many games against celebrated Jeopardy!
champions and was in fact able to beat the 2 greatest players
of all time, Ken Jennings and Brad Rutter in a televised match
in February 2011.The success of Watson prompted IBM to
put the question-answering technology underlying Watson
(called DeepQA) to other uses. Computationally, answering a
question in a game of Jeopardy! is very similar to the task of
compiling a differential diagnosis: Based on a natural language
query (e.g., “ Jewish boy age 16 suffering from monthly seizures,
sleep deficiency, aggressive and irritable when woken, highly
increased sexual appetite and hunger” ), the system has to be
able to quickly figure out what the question is about, and
search a wide variety of heterogeneous, unstructured knowl-
edge sources such as medical textbooks, databases and articles
for an answer. Based on this search, the system then has to
construct a list of candidate answers and evaluate how likely
each of the candidate answers are. The similarity in question
type between Jeopardy! and the task of compiling a differential
diagnosis meant that IBM was able to turn Watson into a
state-of-the-art CDDSS21 relatively fast.
Design of Watson
It took 2-dozen researchers approximately 4 y to develop the
DeepQA technology. The technology became extremely complex
and consists of more than 500.000 lines of code.23 The overall
design is simple, though, and can roughly be broken down into 5
stages:
1. Question and topic analysis. In this stage, natural language
processing is used to discern the nature of the question in
order to construct a structured search query.
2. Hypotheses generation. The search query is used to generate a
list of potential hypotheses, e.g. “The disease is Gilbert’s
syndrome”
3. Evidence and hypotheses scoring. Each hypothesis is scored
along different evidence dimensions (e.g., symptoms, gender,
demographics), and the evidence scores are combined in order
to score the hypothesis
4. Ranking. The hypotheses are combined and a ranked list of
hypotheses is generated based on the hypothesis scores.
5. Answer and confidence. In the last stage a ranked list of
answers is generated and a level of confidence is calculated for
each hypothesis.
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Performance of Watson
In order to estimate the recall@10 performance, the develop-
ers of medical Watson used a set of 5000 medical questions from
the American College of Physicians (ACP). The questions have
been used in a Jeopardy!-like competition, called Doctor’s
Dilemma, that medical interns and residents participate in once a
year. 1322 of the questions were used for training and a separate
set of 188 questions were used for testing. The results are divided
into 4 stages of domain adaption with the following recall@10
performance:
1. Core is the original Watson Jeopardy! system, 40%.
2. CoreCcontent is as in 1), but with medical content adaption,
54%.
3. CoreCcontentCtrain is as in 2), but trained on Doctors
dilemma questions instead of normal Jeopardy! questions,
74%.
4. CoreCcontentCtrainCfunc is as in 3) but with some further
tweaks to the Watson engine in order to optimize it for medi-
cal questions and answers, 77%. We tried obtain this test set
from the IBM Watson team in order to make a comparison
between FindZebra and Watson. Unfortunately, we had no
luck obtaining these questions. Instead we obtained a set of
3000 Doctors’s dilemma questions directly from ACP and
performed the same kind of test as the one performed by the
developers of Watson (but on a different subset of the
Doctor’s dilemma questions). First we removed questions not
related to diagnosis (e.g., questions in the category ethics) and
questions requiring inspection of images. Then we removed
all questions where the answer was not a disease (i.e., we
removed questions where the answer text did not refer to a
disease found on either Wikipedia, Orphanet, Omim, Nord,
Gard or Genetics Home Reference). Synonyms of disease
names were resolved using the UMLS database. This gave a
total of 546 questions that we ran through FindZebra and
found a recall10 of 53%.
The test was performed using a highly conservative computer
program: only when a 100% match was found we reported it as a
success. For example, in the question syndrome name for
hypothalamic hypogonadism and anosmia, the correct answer is
Kallmann’s syndrome. However, Idiopathic hypogonadotropic
hypogonadism with anosmia has been known under the name
Kallmanm’s syndrome, and 18 OMIM articles about this disease
figure among the first 20 search results. Also, Kallmann’ s syn-
drome with spastic paraplegia is found as result 3. The answer is
nevertheless considered wrong because an exact textual match
was not found. This conservative approach thus only gives a
lower bound for the recall@10 performance, but it avoids having
to deal with subjective opinions of which answers can be consid-
ered as correct.
A table showing the recall@20 and recall@10 performance for
each of the major categories in the Doctor’s dilemma dataset can
be found in Figure 2. Even though it might seem that FindZebra
performs better on some question categories than others, there is
no statistical evidence to support this claim (we have tested the
hypothesis that the recall@n was independent of question cate-
gory by using a Pearson x2 test, resulting in a p-value of 0.20 for
recall@20 and a p-value of 0.53 for recall@10).
Because we do not have access to the actual test questions
used by the Watson team, it is only possible to make a very
rough comparison between Watson and FindZebra. When
Watson and FindZebra are given the same prerequisites (i.e.
no training on the Doctor’s dilemma questions), they seem to
perform equally well. However, it should be noted that
Watson has a much better performance if allowed to train on
Doctors dilemma questions. But since search engine queries
do not show anything resembling the structure found in a typ-
ical Doctors dilemma question, it remains to be seen how
much of this performance gain can actually be transferred to a
real setting.
Results for each of the 546 questions can be found at http://
ec2–54–148–37–23.us-west-2.compute.amazonaws.com:8080/
QueriesAndResultsFinalForWeb.xls, and the version of FindZe-
bra used to conduct the tests reported in this paper (including
the test on the 56 cases mentioned previously) can be found here:
http://ec2-54-148-37-23.us-west-2.compute.amazonaws.
com:8080. This version is identical to findzebra.com running on
October 2014. Note that the rank found on the web page is often
a couple of ranks better than reported in the Excel file due to
clustering of documents describing the same disease.
Figure 2. Performance of FindZebra on each of the major disease categories in the Doctor’s dilemma dataset.
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Use of CDDSS System in Practice
Evidence suggests that CDDSS systems have the potential to
reduce diagnostic errors and improve quality of care.24,25,26,27
Furthermore, studies have shown that users of the systems are
actually satisfied with the results they get from the support
tools.28 Despite of this, many physicians are reluctant to use the
systems in practice on a day-to-day basis,28 even when the sup-
port tools are well integrated into their workflow.29,30, 31,32, 33 In
an older review article on the use of the first generations of
CDDSS systems,34 Miller concludes that even though niche sys-
tems for specific areas are perceived as very useful, the perceived
usefulness of the more general systems is less certain, despite the
fact that these systems can often suggest diagnoses that even
expert physicians have not considered. One of the key assump-
tions behind FindZebra is based on these findings, i.e., that a
medical professional will typically not use a CDDSS system on a
daily basis, but only when facing a diffcult problem. So instead
of building a universal question answering system being able to
diagnose all kinds of diseases, FindZebra is designed to be a fast,
easy to use system, optimized for the types of queries that the sys-
tem is expected to encounter in practice, namely queries regard-
ing diseases not encountered often.
Social Media for Diagnosis – Collective Intelligence
and Authority of Experts
It is hard to come up with quantitative statements about the
effect of social media on medical diagnosis because evidence has
not so far been collected systematically and it is still early days
with the organization and tools taking shape. But it is clear that
the potential is huge35 because the web allows for quick knowl-
edge sharing and peer networks with the required knowledge
base can be formed quickly for the case in question. There is
already anecdotal evidence of diagnosis36 and a commercial com-
pany crowdmed.com has made a business case of combining pre-
diction markets with collective intelligence to increase the
accuracy of diagnosis of unsolved cases. Examples of social media
dedicated to health care professionals are doximity.com, sermo.
com and vis.dk. If these initiatives mature to become an integral
part of how physicians work with diagnosis then we can expect to
see this affect diagnosis of rare diseases in the coming years.
Conclusion
Diagnostic errors are primarily caused by defective synthesis of
the available information. Clinical diagnosis decision support sys-
tems (CDDSSs) have the potential of reducing such types of
error, but many physicians are nevertheless reluctant to use them
on a day to day basis, regardless of how well they are integrated
into the workflow. This means that a medical professional is only
likely to use a CDDSS when he or she is facing a particularly diff-
cult problem, such as a rare disease. Our tool FindZebra is an
example of a search engine designed to solve exactly this kind of
problem.
We have already seen a widespread use of the internet to
search for health related information, both among professionals
and non-professionals. There are mixed opinions whether these
tools in the hands of non-professionals have a positive effect on
diagnosis. But non-professional “diagnosis” is a phenomenon
that is likely to grow in the years to come, and considering that
millions of people (just in the United States) consult their physi-
cian based on a self-diagnosis each year, even a modest increase
in diagnostic performance can have a huge impact, and save
time, money and lives. The overall performance of tools such as
Google Search has meant that the diagnostic capabilities of non-
professionals have reached a relatively high level. In this and in
previous articles we have shown that more specialized tools might
have the capabilities to increase this diagnostic performance even
further, for professionals and non-professionals alike.
For the busy medical professional speed is clearly important
for practical usefulness. This argues for simple user-interfaces
that require no training or use of specialized medical vocabulary.
Robust machine learning based interpretation of free text queries
is therefore a major challenge for the developer of such a system.
Combining ideas from free text search and menu/fixed vocabu-
lary based CDDSSs may in the end provide the most accurate
and useful systems.
Many initiatives based upon information technology and new
means of knowledge sharing are appearing in these years, and the
rapid growth of websites such as doximity.com, sermo.com and
others indicate that it is an area with a lot of potential. However,
the full effect of these social media sites on the diagnostic process,
remains to be seen.
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